Pharmacokinetics and haemodynamic effects of ISDN following different dosage forms and routes of administration

Abstract

The pharmacokinetics and haemodynamic effects of isosorbide dinitrate (ISDN) have been investigated following administration of single doses as a sublingual (SL) spray (2.5 mg), sublingual tablet (5 mg) and peroral tablet (10 mg) in a randomised, placebo-controlled double-blind cross-over trial in 16 healthy volunteers. After the sublingual spray Cmax was higher (39.0 ng.ml-1) and tmax was shorter (3.9 min) than after the sublingual (22.8 ng.ml-1 and 13.8 min) and peroral (16.9 ng.ml-1 and 25.6 min) tablets. The AUC of ISDN did not differ following any of the three formulations (1031; 879; 997 ng.ml-1.min, for the spray, SL tablet and PO-tablet, respectively). Mononitrate metabolites of ISDN (IS-2-MN and IS-5-MN) and total nitrates in plasma increased in proportion to the administered dose. This indicates that the fraction of the dose absorbed was the same for all the formulations but that the extent of first-pass metabolism increased in the order sublingual spray < sublingual tablet < peroral tablet. Thus, compared to the spray, the relative bioavailability of ISDN was 48% and 28% from the sublingual and peroral tablets, respectively. The haemodynamic effects were quantified using the a/b ratio of the finger pulse wave and the systolic blood pressure and heart rate under orthostatic conditions.(ABSTRACT TRUNCATED AT 250 WORDS)

Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging

“…The t max . of isosorbide after sublingual administration is less than 10 min; in addition, the plasma elimination half‐life of isosorbide after sublingual administration is 45–60 min, 51–54 suggesting that high circulating levels were achieved for the entire 30 min of fasting and postprandial measurements.…”

Drug safety: The concept, inception and its importance in patients’ health

“…For example, a medication can be formulated in the form of syrups, tablets, capsules, and suppositories. This may have an impact as each dosage form has a different pharmacokinetic profile, especially as regards their absorption rate – e.g., syrups have faster absorption than tablets or suppositories – and thus the dose should be taken as prescribed by the physician and reviewed by the pharmacist (Levy, 1964, Vogt et al, 1994).…”

Effect of Sustained-Release Isosorbide Dinitrate on Post-Prandial Gastric Emptying and Gastroduodenal Motility in Healthy Humans

“…Isosorbide dinitrate is a lipophilic substance that is quickly absorbed from the gastrointestinal tract. 20 After the ingestion of a sustained-release tablet of isosorbide dinitrate, the pharmacological effective plasma concentration of this drug is reached in 15 -30 min and maintained for the following 8-to 12-h period. The peak plasma level is reached in 30 -60 min.…”